We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENG
11776
CALL
DELISTED
ENGlobal Corp
ENG
$55K ﹤0.01%
7,238
-2,037
-22% -$18.6K
BCEL
11777
CALL
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$55K ﹤0.01%
30,600
-20,000
-40% -$41.8K
TRHC
11778
CALL
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$55K ﹤0.01%
21,300
+5,600
+36% +$21K
CLVR
11779
PUT
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
$55K ﹤0.01%
1,877
-2,083
-53% -$83.2K
OIG
11780
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$55K ﹤0.01%
+2,208
New +$97.9K
FVIV.WS
11781
DELISTED
Fortress Value Acquisition Corp. IV Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
FVIV.WS
$55K ﹤0.01%
294,504
-18,092
-6% -$6.75K
BKEP
11782
CALL
DELISTED
Blueknight Energy Partners L.P.
BKEP
$55K ﹤0.01%
12,100
-10,600
-47% -$45.1K
EVFM
11783
PUT
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$55K ﹤0.01%
48,420
+46,220
+2,101% +$76.2K
BBAR icon
11784
CALL
BBVA Argentina
BBAR
$3.13B
$54K ﹤0.01%
22,800
+9,300
+69% +$27.6K
BCLI
11785
PUT
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$54K ﹤0.01%
1,293
-534
-29% -$24K
BZFD icon
11786
CALL
BuzzFeed
BZFD
$92.5M
$54K ﹤0.01%
8,825
-2,975
-25% -$44.9K
EPIX
11787
CALL
DELISTED
ESSA Pharma
EPIX
$54K ﹤0.01%
17,100
-4,500
-21% -$25.1K
OKYO
11788
OKYO Pharma
OKYO
$79.8M
$54K ﹤0.01%
+26,864
New +$60.4K
RAVE icon
11789
RAVE Restaurant Group
RAVE
$43.2M
$54K ﹤0.01%
+49,735
New +$49.3K
RGS icon
11790
CALL
Regis Corp
RGS
$69.3M
$54K ﹤0.01%
2,520
-110
-4% -$2.48K
THMO
11791
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
$54K ﹤0.01%
+4,338
New +$85.5K
VINO
11792
DELISTED
Gaucho Group Holdings, Inc. Common Stock
VINO
$54K ﹤0.01%
+74
New +$121K
VELOW
11793
DELISTED
Velocity Acquisition Corp. Warrant
VELOW
$54K ﹤0.01%
536,030
-102,036
-16% -$20.6K
AUTL
11794
CALL
Autolus Therapeutics
AUTL
$572M
$53K ﹤0.01%
+18,600
New +$56.6K
FLUX icon
11795
Flux Power
FLUX
$12.7M
$53K ﹤0.01%
22,289
-10,272
-32% -$25.4K
KPLT icon
11796
PUT
Katapult Holdings
KPLT
$36.7M
$53K ﹤0.01%
1,968
-2,520
-56% -$99.7K
ROIV icon
11797
CALL
Roivant Sciences
ROIV
$26.1B
$53K ﹤0.01%
+12,900
New +$51.2K
TNON icon
11798
Tenon Medical
TNON
$2.56M
$53K ﹤0.01%
+8
New +$233K
VNRX icon
11799
VolitionRx Ltd
VNRX
$6.89M
$53K ﹤0.01%
1,284
-23
-2% -$1.16K
IRD
11800
CALL
Opus Genetics
IRD
$300M
$53K ﹤0.01%
27,600
-5,400
-16% -$12.3K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.